May 16, 2023
Gene Editing and Immunotherapeutic Targeting of ADGRE2/EMR2 to Enable Combinatorial Targeting in Acute Myeloid Leukemia (AML)
Discovery Platform, Platform
Presented by: Julia Etchin, PhD – Discovery and Molecular Engineering – Vor Bio
ASGCT – 2023 – Poster Presentation 618